Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Psychiatry Research|May 30, 2021
Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatmentFreda Scheffler, Lebogang Phahladira, Hilmar Luckhoff, et al.
Schizophrenia Bulletin|June 4, 2018
Childhood Trauma Associated White Matter Abnormalities in First-Episode SchizophreniaLaila Asmal, Sanja Kilian, Stefan du Plessis, et al.
Schizophrenia Research|July 6, 2014
A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophreniaRobin Emsley, Bonginkosi Chiliza, Laila Asmal, et al.
Global Mental Health (Cambridge, England)|September 2, 2025
The concordance between the Montreal cognitive assessment and the repeatable battery for the assessment of neuropsychological status as a cognitive screening tool in a south African community sampleSharain Suliman, Erine Bröcker, Natalie Beath, et al.
Psychiatry Research|July 18, 2015
Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophreniaRobin Emsley, Laila Asmal, Bonginkosi Chiliza, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|December 1, 2022
Healthcare Utilization 12 Months Prior to Fatal and Non-fatal Suicidal Behaviour in Cape Town, South AfricaTahira Kootbodien, Jason Bantjes, John Joska, et al.
Psychiatry Research|February 5, 2021
The course and concomitants of depression in first-episode schizophrenia spectrum disorders: A 24-month longitudinal studyLebogang Phahladira, Laila Asmal, Hilmar K Lückhoff, et al.
Psychological Medicine|April 20, 2022
Antipsychotic treatment effects and structural MRI brain changes in schizophreniaRobin Emsley, Stefan du Plessis, Lebogang Phahladira, et al.
Early Intervention in Psychiatry|February 2, 2022
The associations of cannabis and methamphetamine use with cognitive performance over the first 2 years of treatment in schizophrenia spectrum disordersFreda Scheffler, Lebogang Phahladira, Chanellé B Hendrikse, et al.
Schizophrenia Research|January 29, 2017
Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effectsRobin Emsley, Bonginkosi Chiliza, Laila Asmal, et al.
Pageof 7